Hematology & Oncology

Medicine & Life Sciences

1. emicizumab 100%
2. Antiphospholipid Syndrome 94%
3. low density lipoprotein receptor-related protein 8 93%
4. Acquired Factor 8 deficiency 87%
5. Lymphomatoid Granulomatosis 85%
6. Rituximab 85%
7. Scurvy 81%
8. Hemarthrosis 76%
9. Thrombotic Thrombocytopenic Purpura 70%
10. Lenalidomide 69%
11. von Willebrand Diseases 69%
12. Protein Phosphatase 2 68%
13. Hemolytic-Uremic Syndrome 66%
14. Paraproteinemias 65%
15. Antiphospholipid Antibodies 65%
16. Thrombophilia 62%
17. Trophoblasts 57%
18. Idiopathic Thrombocytopenic Purpura 56%
19. Coronary Thrombosis 54%
20. Pre-Eclampsia 52%
21. Ascorbic Acid 52%
22. Thrombocytopenia 49%
23. Transplant Recipients 48%
24. Heparin 47%
25. von Willebrand Factor 46%
26. Fetal Growth Retardation 43%
27. Coronary Vessels 42%
28. Central Nervous System 38%
29. Hypoxia-Inducible Factor 1 33%
30. Knee 31%
31. Factor VIII 29%
32. Endoglin 28%
33. Kidney 28%
34. Lymphoproliferative Disorders 27%
35. Prolyl Hydroxylases 27%
36. Glioblastoma 25%
37. Placenta 24%
38. Hemorrhage 23%
39. Up-Regulation 23%
40. Fetal Death 23%
41. Arthrocentesis 20%
42. Protein Domains 19%
43. Protein S Deficiency 19%
44. Allografts 19%
45. prothrombin complex concentrates 18%
46. Recurrence 18%
47. recombinant FVIIa 18%
48. Ecchymosis 18%
49. Radiotherapy 18%
50. Thrombotic Microangiopathies 17%
51. Essential Thrombocythemia 17%
52. factor V Leiden 17%
53. Polycythemia Vera 16%
54. Pediatrics 16%
55. Antithrombins 16%
56. Prothrombin 15%
57. Diet Therapy 15%
58. Pain 15%
59. Monoclonal Gammopathy of Undetermined Significance 14%
60. Hemophilia A 14%
61. Protein C 14%
62. Propensity Score 14%
63. Metalloproteases 14%
64. Acetaminophen 13%
65. Hemostatics 13%
66. Deamino Arginine Vasopressin 13%
67. Head and Neck Neoplasms 13%
68. Immunoglobulin G 12%
69. Plasma Exchange 12%
70. Platelet Count 12%
71. Proteinuria 12%
72. Age Groups 12%
73. Anticoagulants 12%
74. Autoantibodies 12%
75. Upper Extremity 11%
76. Serum 11%
77. Pregnancy 11%
78. Atrial Fibrillation 11%
79. Anemia 11%
80. Calcineurin Inhibitors 10%
81. Hematologic Neoplasms 10%
82. Lower Extremity 10%
83. Hospital Emergency Service 10%
84. Hemostasis 10%
85. Swine 10%
86. Survival 9%
87. Dexamethasone 9%
88. Myocardial Infarction 9%
89. Therapeutics 9%
90. Lymphoma 8%
91. Hypertension 8%
92. Neoplasms 8%
93. Mothers 8%
94. B-Lymphocytes 8%
95. Enzyme Assays 7%
96. Mutation 7%
97. Costs and Cost Analysis 6%
98. Immunoblotting 6%
99. Wounds and Injuries 6%
100. Proteins 6%